Feed Category: Healthcare

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood thinner Eliquis and a portfolio of drugs… [Read More]

Continued progress toward submission of 5th and final module of FDA premarket approval (PMA) application for VenoValve® in Q4 GLP study for enVVe® transcatheter-based replacement… [Read More]

MOUNTAIN VIEW, Calif., October 31, 2024–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today… [Read More]

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and… [Read More]

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and… [Read More]

Ninety people in 13 states have been infected in a deadly E. coli outbreak linked to McDonald’s Quarter Pounders, the CDC said. The outbreak has… [Read More]

MOUNTAIN VIEW, Calif., October 30, 2024–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today… [Read More]

MOUNTAIN VIEW, Calif., October 30, 2024–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today… [Read More]

LEHI, Utah, October 30, 2024–(BUSINESS WIRE)–Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024… [Read More]

LEHI, Utah, October 30, 2024–(BUSINESS WIRE)–Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024… [Read More]

All doses of Novo Nordisk’s weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the… [Read More]

All doses of Novo Nordisk’s weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the… [Read More]